Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Triptorelin Pamoate,Inapplicable
Therapeutic Area : Oncology
Study Phase : Phase IV
Sponsor : Manyak, Michael, M.D. | Watson Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Details : Undisclosed
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
April 25, 2016
Lead Product(s) : Triptorelin Pamoate,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Phase IV
Sponsor : Manyak, Michael, M.D. | Watson Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable